What is BESPOKE EXTRACTS INC's earnings per share (EPS)?

BESPOKE EXTRACTS INC (BSPK) reported diluted earnings per share of -$0.10 for fiscal year 2024. This represents a 33.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

BESPOKE EXTRACTS INC (BSPK) Financials

BSPK

FY2024 annual

Revenue $1.1M +42.3% YoY

Net Income -$1.0M +30.0% YoY

EPS (Diluted) -$0.10 +33.3% YoY

Free Cash Flow -$890K YoY not available

Market Cap $18K as of Sep 11, 2026

Price / Sales 0.0x on $1.4M revenue, trailing 12 months to September 30, 2025

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2025

Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Nov 12, 2025 Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2025, filed Nov 12, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BSPK SEC filings page.

BESPOKE EXTRACTS INC (BSPK) reported $1.1M in revenue for fiscal year 2024, up 42.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BSPK FY2024 2026-08-30

Bespoke Extracts is expanding sales, but overhead and capital spending still absorb the economics before they become earnings or cash.

In FY2024, gross margin fell to 40.5% while operating margin improved to -89.0%; that combination points to SG&A reduction—not stronger gross economics—as the main reason losses narrowed. Operating cash flow improved to -$289.8K, but FCF remained -$889.8K, showing that capital spending absorbed the improvement.

Liabilities reached $2.5M against $359.1K of assets, a structure dominated by obligations rather than owned capital. Negative equity was -$2.1M and the current ratio was 0.1x, indicating that near-term obligations were not matched by current assets.

The company generated $343.5K through financing while operating cash flow was -$289.8K; reported operations therefore still depended on outside funding during FY2024.

Financial Health Signals

Financial health score not available

BESPOKE EXTRACTS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-112.15

BESPOKE EXTRACTS INC scores -112.15, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($18K) relative to total liabilities ($2.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/8

BESPOKE EXTRACTS INC passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

BESPOKE EXTRACTS INC reported a net loss of $1.0M while operations used $290K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

BESPOKE EXTRACTS INC reported an operating loss of $995K against $60K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$468K

YoY+68.6%

QoQ+19.8%

BESPOKE EXTRACTS INC generated $468K in revenue in Q3 2025. This represents an increase of 68.6% from the same quarter a year earlier. Against the prior quarter it is up 19.8%.

EBITDA

-$51K

YoY+80.4%

QoQ+68.1%

BESPOKE EXTRACTS INC's EBITDA was -$51K in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 80.4% from the same quarter a year earlier. Against the prior quarter it is up 68.1%.

Net Income

-$78K

YoY+71.7%

QoQ+61.9%

BESPOKE EXTRACTS INC reported -$78K in net income in Q3 2025. This represents an increase of 71.7% from the same quarter a year earlier. Against the prior quarter it is up 61.9%.

EPS (Diluted)

-$0.01

YoY+66.7%

QoQ+50.0%

BESPOKE EXTRACTS INC earned -$0.01 per diluted share (EPS) in Q3 2025. This represents an increase of 66.7% from the same quarter a year earlier. Against the prior quarter it is up 50.0%.

Cash & Balance Sheet

Free Cash Flow

-$20K

QoQ+36.7%

BESPOKE EXTRACTS INC recorded an outflow of $20K in free cash flow in Q3 2025, representing a cash shortfall after capex. Against the prior quarter it is up 36.7%.

Cash & Debt

$17K

YoY-21.9%

QoQ+1128.4%

BESPOKE EXTRACTS INC held $17K in cash as of Q3 2025; long-term debt is not reported for that period.

Shares Outstanding

11M

YoY+1.2%

QoQ+0.9%

5Y CAGR-45.3%

10Y CAGR+14.4%

BESPOKE EXTRACTS INC had 11M shares outstanding in Q3 2025. This represents an increase of 1.2% from the same quarter a year earlier. Against the prior quarter it is up 0.9%.

Dividends Per Share

Not reported for Q3 2025.

Margins & Returns

Gross Margin

50.0%

YoY+8.6pp

QoQ-0.5pp

BESPOKE EXTRACTS INC's gross margin was 50.0% in Q3 2025, indicating the percentage of revenue retained after direct costs. This is up 8.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.

Operating Margin

-11.5%

YoY+83.1pp

QoQ+29.9pp

BESPOKE EXTRACTS INC's operating margin was -11.5% in Q3 2025, reflecting core business profitability. This is up 83.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 29.9 percentage points.

Net Margin

-16.7%

YoY+82.6pp

QoQ+35.8pp

BESPOKE EXTRACTS INC's net profit margin was -16.7% in Q3 2025, showing the share of revenue converted to profit. This is up 82.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 35.8 percentage points.

Return on Equity

Not reported for Q3 2025.

Capital Allocation

Capital Expenditures

BESPOKE EXTRACTS INC reported no capital expenditure in Q3 2025.

R&D Spending

Not reported for Q3 2025.

Share Buybacks

Not reported for Q3 2025.

BSPK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BSPK quarterly income statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.4M	$1.1M+42.3%	$785K+22954.1%	$3K-90.4%	$36K+341.6%	$8K-87.0%	$62K+290.1%	$16K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	$751K	$665K+50.2%	$442K+38393.4%	$1K-91.5%	$14K+287.1%	$4K-95.1%	$71K+211.5%	$23K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$672K	$453K+32.0%	$343K+15097.7%	$2K-89.7%	$22K+383.6%	$5K+148.9%	-$9K-32.9%	-$7K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.2M	$1.3M-19.4%	$1.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$31K-66.8%	$92K-71.0%	$318K-18.8%	$392K	N/A
Operating Income	-$640K	-$995K+32.4%	-$1.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$731K-86.0%	-$393K	N/A	N/A	N/A
EBITDA	N/A	-$985K+32.7%	-$1.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$389K	N/A	N/A	N/A
Interest Expense	N/A	$60K+452.9%	$11K	N/A	N/A	$536K+49.9%	$357K-14.7%	$419K+561.8%	$63K+17245.5%	$365	N/A	$1K	N/A	N/A	N/A
Net Income	-$731K	-$1.0M+30.0%	-$1.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$731K-85.6%	-$394K-22.5%	-$322K+17.9%	-$392K	N/A
EPS (Basic)	N/A	-$0.10+33.3%	-$0.15+65.9%	-$0.44-131.6%	-$0.19	N/A	$0.04+119.0%	-$0.21	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	-$0.07	-$0.10+33.3%	-$0.15+65.9%	-$0.44-131.6%	-$0.19	N/A	$0.04+119.0%	-$0.21	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	11M+3.5%	10M+8.6%	9M+81.6%	5M	N/A	61M+71.1%	35M	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Revenue	$468K+68.6%	$391K+40.4%	$263K+1.0%	$301K+14.3%	$277K+13.5%	$278K+47.8%	$260K+192.6%	$264K
Cost of Revenue	$234K+43.9%	$193K+12.2%	$152K-3.5%	$172K+71.4%	$162K+11.3%	$172K+46.8%	$158K+100.7%	$100K
Gross Profit	$234K+103.6%	$197K+86.1%	$111K+8.0%	$129K-20.9%	$115K+16.9%	$106K+49.4%	$103K+891.2%	$163K
SG&A Expenses	$260K-28.0%	$338K+3.6%	$313K-10.0%	$244K-40.0%	$361K+3.9%	$326K-28.7%	$348K-7.1%	$407K
Operating Income	-$54K+79.5%	-$162K+35.3%	-$245K+19.0%	-$179K+32.4%	-$262K+11.4%	-$250K+46.5%	-$303K+31.7%	-$265K
EBITDA	-$51K+80.4%	-$160K+35.8%	-$244K+18.6%	-$177K+43.2%	-$260K+6.2%	-$248K+44.6%	-$299K+29.6%	-$313K
Interest Expense	$4K	$4K	N/A	$49K+348.8%	$0-100.0%	$0+100.0%	$11K+511.5%	$11K
Net Income	-$78K+71.7%	-$205K+21.4%	-$261K+17.1%	-$187K+32.2%	-$276K+8.6%	-$261K+43.9%	-$314K+28.7%	-$276K
EPS (Basic)	-$0.01+66.7%	-$0.02+33.3%	-$0.02+33.3%	-$0.02+33.3%	-$0.030.0%	-$0.03+40.0%	-$0.03+25.0%	-$0.03+25.0%
EPS (Diluted)	-$0.01+66.7%	-$0.02+33.3%	-$0.02+33.3%	-$0.02	-$0.030.0%	-$0.03+40.0%	-$0.03+25.0%	-$0.10-150.0%
Diluted Shares (Avg)	11M+5.8%	11M+9.7%	11M+9.7%	N/A	11M+4.6%	10M0.0%	10M+0.6%	N/A

Not reported in any period shown, so not listed: R&D Expenses, Income Tax.

BSPK Balance Sheet

BSPK quarterly balance sheet

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$359K+1.3%	$354K-13.5%	$410K+228.9%	$125K-25.1%	$166K+109.3%	$79K-63.9%	$220K+41.2%	$156K+8819.0%	$2K-99.4%	$283K-63.7%	$778K+13.0%	$688K-8.8%	$755K+225936.8%	$334
Current Assets	$165K+101.9%	$82K-26.8%	$112K+25.5%	$89K-32.8%	$133K+252.4%	$38K-78.5%	$175K+63.0%	$107K+24754.8%	$431-99.8%	$207K-52.7%	$438K0.0%	$438K-41.0%	$742K+222092.5%	$334
Cash & Equivalents	$60K+812.7%	$7K-73.0%	$24K+118.6%	$11K-91.2%	$127K+1124.0%	$10K-87.0%	$80K-8.5%	$87K+20125.5%	$431-99.8%	$186K-57.5%	$438K0.0%	$438K-40.3%	$733K	N/A
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A
Inventory	$33K+105.9%	$16K	$0-100.0%	$48K	$0-100.0%	$3K-94.9%	$62K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$57K+26.6%	$45K	N/A	$5K+46.8%	$4K-44.4%	$6K+222.0%	$2K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A
Total Liabilities	$2.5M+17.9%	$2.1M+92.2%	$1.1M+138.7%	$453K-33.3%	$680K+512.2%	$111K-82.8%	$647K+51.3%	$428K+270.2%	$116K+266.6%	$32K+488.2%	$5K-75.1%	$21K+30.0%	$17K-74.5%	$65K
Current Liabilities	$1.1M+3.7%	$1.1M+24.6%	$866K	N/A	$680K+512.2%	$111K-80.4%	$566K+141.4%	$235K+103.0%	$116K+266.6%	$32K+488.2%	$5K-75.1%	$22K+30.1%	$17K+87.4%	$9K
Non-Current Liabilities	$1.3M+33.2%	$1000K+362.9%	$216K+341.2%	-$90K	$0	$0-100.0%	$81K-58.0%	$193K	$0	$0	$0+100.0%	-$1	$0-100.0%	$56K
Total Equity	-$2.1M-21.3%	-$1.7M-156.6%	-$672K-104.5%	-$329K+36.0%	-$514K-1523.9%	-$32K+92.6%	-$428K-57.1%	-$272K-139.1%	-$114K-145.3%	$251K-67.5%	$772K+15.8%	$667K-9.7%	$738K+1245.2%	-$64K
Retained Earnings	-$26.4M-4.1%	-$25.4M-6.2%	-$23.9M-21.0%	-$19.7M-5.1%	-$18.8M-32.8%	-$14.1M+15.4%	-$16.7M-83.6%	-$9.1M-275.1%	-$2.4M-17.7%	-$2.1M-54.9%	-$1.3M	N/A	N/A	N/A

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Total Assets	$296K-12.6%	$267K-27.3%	$248K-30.3%	$359K+1.3%	$338K-12.9%	$367K-18.0%	$356K-25.6%	$354K-13.5%
Current Assets	$197K+58.7%	$155K+15.9%	$123K+18.6%	$165K+101.9%	$124K+27.9%	$134K-3.1%	$104K-30.3%	$82K-26.8%
Cash & Equivalents	$17K-21.9%	$1K-94.5%	$30K+110.6%	$60K+812.7%	$21K	$25K+1173.3%	$14K+230.3%	$7K-73.0%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$64K+43.9%	$42K+29.1%	$39K+0.1%	$33K+105.9%	$44K+73.1%	$32K-23.7%	$39K+198.8%	$16K
Accounts Receivable	$104K+124.7%	$101K+70.7%	$37K-14.8%	$57K+26.6%	$46K+0.3%	$59K+39.9%	$43K-7.2%	$45K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$2.9M+8.4%	$2.8M+10.5%	$2.6M+10.9%	$2.5M+17.9%	$2.7M+37.4%	$2.5M+41.8%	$2.3M+60.7%	$2.1M+92.2%
Current Liabilities	$1.9M+8.4%	$1.5M-5.6%	$1.2M-7.7%	$1.1M+3.7%	$1.7M+86.7%	$1.6M+107.6%	$1.3M+7.7%	$1.1M+24.6%
Non-Current Liabilities	$1.0M+8.4%	$1.3M+36.7%	$1.3M+36.4%	$1.3M+33.2%	$940K-7.6%	$966K-6.5%	$983K+391.8%	$1000K+362.9%
Total Equity	-$2.6M-11.4%	-$2.5M-16.9%	-$2.3M-18.3%	-$2.1M-21.3%	-$2.3M-49.9%	-$2.2M-61.0%	-$2.0M-103.3%	-$1.7M-156.6%
Retained Earnings	-$26.9M-2.8%	-$26.9M-3.6%	-$26.7M-3.8%	-$26.4M-4.1%	-$26.2M-4.5%	-$25.9M-4.6%	-$25.7M-5.6%	-$25.4M-6.2%

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

BSPK Cash Flow Statement

BSPK quarterly cash flow statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$260K	-$290K+30.2%	-$415K+48.0%	-$798K	N/A	-$465K	N/A	-$748K-77.1%	-$422K	N/A	-$252K+38.0%	-$406K-33.7%	-$304K+26.5%	-$413K	N/A
Depreciation & Amortization	N/A	$10K+7.5%	$9K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4K0.0%	$4K+2799.2%	$131	N/A
Stock-Based Compensation	N/A	$198K-48.1%	$380K-87.1%	$3.0M	$0-100.0%	$3.5M+347.0%	-$1.4M-121.6%	$6.5M+3.6%	$6.3M	N/A	$115K	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	$600K	N/A	$7K+162.4%	$3K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	-$890K	N/A	-$805K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	-$88K-1661.2%	-$5K	N/A	N/A	$90K+262.7%	$25K	N/A	N/A	-$93K	N/A	N/A	N/A
Financing Cash Flow	$255K	$344K-13.6%	$397K-47.9%	$762K	N/A	$582K	N/A	$650K+34.2%	$485K	N/A	N/A	$500K	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$28K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Operating Cash Flow	-$20K+30.8%	-$31K-10.2%	-$73K+25.0%	-$136K-588.7%	-$28K-504.4%	-$28K+85.6%	-$97K+53.1%	-$20K+89.8%
Depreciation & Amortization	$3K+16.6%	$2K+25.7%	$2K-48.3%	$3K+46.6%	$3K-86.4%	$2K-89.9%	$3K-81.0%	$2K
Stock-Based Compensation	N/A	N/A	$3K-94.1%	N/A	N/A	N/A	$50K-45.5%	N/A
Capital Expenditures	$0	$0	$600K	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	-$20K	-$31K	-$673K	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$35K+40.0%	$2K-94.8%	$43K-59.0%	$175K+563.5%	$25K+379.1%	$39K-80.0%	$105K-43.9%	$26K-89.7%

Not reported in any period shown, so not listed: Investing Cash Flow, Dividends Paid, Share Buybacks.

BSPK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BSPK quarterly financial ratios

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	40.5%-3.2pp	43.7%-22.6pp	66.3%+4.4pp	61.9%+5.4pp	56.5%+71.5pp	-15.0%+29.0pp	-44.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-89.0%	-187.4%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-92.8%	-188.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-291.1%-240.1pp	-51.0%-2.8pp	-48.2%+4.8pp	-53.0%	N/A
Return on Assets	-288.9%+129.5pp	-418.5%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-258.6%-208.0pp	-50.7%-3.9pp	-46.7%+5.2pp	-51.9%	N/A
Current Ratio	0.15+0.1x	0.08-0.1x	0.13	N/A	0.19-0.1x	0.340.0x	0.31-0.1x	0.46+0.5x	0.00-6.6x	6.56-75.1x	81.70+61.3x	20.37-24.5x	44.89+44.9x	0.04
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.13+0.1x	0.010.0x	0.030.0x	0.02	N/A
Asset Turnover	3.11+0.9x	2.22+2.2x	0.01-0.3x	0.29+0.2x	0.05-0.7x	0.78+0.7x	0.07	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	-79.6%	N/A	-23635.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Gross Margin	50.0%+8.6pp	50.6%+12.4pp	42.1%+2.7pp	42.9%-19.0pp	41.4%+1.2pp	38.1%+0.4pp	39.4%+27.8pp	61.9%
Operating Margin	-11.5%+83.1pp	-41.5%+48.5pp	-93.2%	-59.4%	-94.6%	-90.0%	-116.3%	-100.4%
Net Margin	-16.7%+82.6pp	-52.5%+41.3pp	-99.0%	-62.0%	-99.3%	-93.8%	-120.6%	-104.6%
Return on Assets	-26.4%+55.1pp	-76.8%-5.8pp	-105.0%-16.7pp	-52.0%+25.8pp	-81.5%-3.8pp	-71.0%+32.7pp	-88.3%+3.8pp	-77.8%
Current Ratio	0.110.0x	0.100.0x	0.100.0x	0.15+0.1x	0.070.0x	0.08-0.1x	0.080.0x	0.08-0.1x
Asset Turnover	1.58+0.8x	1.46+0.7x	1.06+0.3x	0.84+0.1x	0.82+0.2x	0.76+0.3x	0.73+0.5x	0.74
FCF Margin	-4.2%	-7.9%	-255.7%	N/A	N/A	N/A	N/A	N/A

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$2.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.15), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
BESPOKE EXTRACTS INC BSPK	FY2024	$1.1M	-$1.0M	-92.8%	$18K	—
TILT HLDGS INC TLLTF	FY2024	$115.6M	-$99.7M	-86.2%	$44K	—
BODY AND MIND INC BMMJ	FY2023	$22.8M	-$20.6M	-90.1%	$30K	—
CTT PHARMACEUTICAL HLDGS CTTH	FY2014	N/A	-$672K	N/A	$2.8M	—

Where BESPOKE EXTRACTS INC Ranks

Frequently Asked Questions

What is BESPOKE EXTRACTS INC's annual revenue?

BESPOKE EXTRACTS INC (BSPK) reported $1.1M in total revenue for fiscal year 2024. This represents a 42.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BESPOKE EXTRACTS INC's revenue growing?

BESPOKE EXTRACTS INC (BSPK) revenue grew by 42.3% year-over-year, from $785K to $1.1M in fiscal year 2024.

Is BESPOKE EXTRACTS INC profitable?

No, BESPOKE EXTRACTS INC (BSPK) reported a net income of -$1.0M in fiscal year 2024, with a net profit margin of -92.8%.

What is BESPOKE EXTRACTS INC's EBITDA?

BESPOKE EXTRACTS INC (BSPK) had EBITDA of -$985K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is BESPOKE EXTRACTS INC's gross margin?

BESPOKE EXTRACTS INC (BSPK) had a gross margin of 40.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is BESPOKE EXTRACTS INC's operating margin?

BESPOKE EXTRACTS INC (BSPK) had an operating margin of -89.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is BESPOKE EXTRACTS INC's net profit margin?

BESPOKE EXTRACTS INC (BSPK) had a net profit margin of -92.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is BESPOKE EXTRACTS INC's free cash flow?

BESPOKE EXTRACTS INC (BSPK) recorded an outflow of $890K in free cash flow during fiscal year 2024. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is BESPOKE EXTRACTS INC's operating cash flow?

BESPOKE EXTRACTS INC (BSPK) recorded an outflow of $290K in operating cash flow during fiscal year 2024, representing cash used by core business activities.

What are BESPOKE EXTRACTS INC's total assets?

BESPOKE EXTRACTS INC (BSPK) had $359K in total assets as of fiscal year 2024, including both current and long-term assets.

What are BESPOKE EXTRACTS INC's capital expenditures?

BESPOKE EXTRACTS INC (BSPK) invested $600K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does BESPOKE EXTRACTS INC have outstanding?

BESPOKE EXTRACTS INC (BSPK) had 11M shares outstanding as of fiscal year 2024.

What is BESPOKE EXTRACTS INC's current ratio?

BESPOKE EXTRACTS INC (BSPK) had a current ratio of 0.15 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is BESPOKE EXTRACTS INC's return on assets (ROA)?

BESPOKE EXTRACTS INC (BSPK) had a return on assets of -288.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is BESPOKE EXTRACTS INC's P/E ratio?

BESPOKE EXTRACTS INC (BSPK) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2025). The market capitalization is $18K as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is BESPOKE EXTRACTS INC's price-to-sales ratio?

BESPOKE EXTRACTS INC (BSPK) trades at 0.0x sales, its market capitalization divided by revenue of $1.4M revenue, trailing 12 months to September 30, 2025. The market capitalization is $18K as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does BESPOKE EXTRACTS INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2024, BESPOKE EXTRACTS INC (BSPK) held $60K in cash, cash equivalents and investments, and reported an operating cash outflow of $290K over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is BESPOKE EXTRACTS INC's debt-to-equity ratio negative or not reported?

BESPOKE EXTRACTS INC (BSPK) has negative shareholder equity of -$2.1M as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is BESPOKE EXTRACTS INC's Altman Z-Score?

BESPOKE EXTRACTS INC (BSPK) has an Altman Z-Score of -112.15, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is BESPOKE EXTRACTS INC's Piotroski F-Score?

BESPOKE EXTRACTS INC (BSPK) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are BESPOKE EXTRACTS INC's earnings high quality?

BESPOKE EXTRACTS INC (BSPK) reported a net loss of $1.0M while operations used $290K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can BESPOKE EXTRACTS INC cover its interest payments?

BESPOKE EXTRACTS INC (BSPK) reported an operating loss of $995K against $60K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.